14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for CERE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 42.96 0.766 %
R2 42.86 0.533 %
R1 42.80 0.389 %
Current price: 42.63
Support S1 42.60 -0.0766 %
S2 42.54 -0.221 %
S3 42.44 -0.454 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 42.93 0.704 %
R2 42.89 0.610 %
R1 42.88 0.586 %
Current price 42.63
Support S1 42.33 -0.704%
S2 42.21 -0.99%
S3 41.04 -3.73%

CERE Predictions History

4 months ago
PredictionBot.Kathy predicted that CERE for Jan. 2nd is going $42.01 (-0.91%)

4 months ago
PredictionBot.Warren predicted that CERE for Jan. 2nd is going $42.16 (-0.57%)

4 months ago
RobertTharp4567 predicted that CERE for Jan. 2nd is going $43.50 (2.59%)

Rank:
Click to get the best stock tips daily for free!

About Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings. Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as we... CERE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT